These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33923318)

  • 1. Anti-Atherosclerotic Potential of Free Fatty Acid Receptor 4 (FFAR4).
    Kiepura A; Stachyra K; Olszanecki R
    Biomedicines; 2021 Apr; 9(5):. PubMed ID: 33923318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Anti-Atherosclerotic Action of FFAR4 Agonist TUG-891 in ApoE-Knockout Mice Is Associated with Increased Macrophage Polarization towards M2 Phenotype.
    Kiepura A; Stachyra K; Wiśniewska A; Kuś K; Czepiel K; Suski M; Ulatowska-Białas M; Surmiak M; Olszanecki R
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575934
    [No Abstract]   [Full Text] [Related]  

  • 3. Free fatty acid receptors as therapeutic targets for the treatment of diabetes.
    Ichimura A; Hasegawa S; Kasubuchi M; Kimura I
    Front Pharmacol; 2014; 5():236. PubMed ID: 25414667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free Fatty Acid Receptors as Mediators and Therapeutic Targets in Liver Disease.
    Secor JD; Fligor SC; Tsikis ST; Yu LJ; Puder M
    Front Physiol; 2021; 12():656441. PubMed ID: 33897464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of free fatty acid receptor 1 in EOC: A novel strategy to restrict the adipocyte-EOC dependence.
    Munkarah A; Mert I; Chhina J; Hamid S; Poisson L; Hensley-Alford S; Giri S; Rattan R
    Gynecol Oncol; 2016 Apr; 141(1):72-9. PubMed ID: 27016232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-atherosclerotic action of GW9508 - Free fatty acid receptors activator - In apoE-knockout mice.
    Suski M; Kiepura A; Wiśniewska A; Kuś K; Skałkowska A; Stachyra K; Stachowicz A; Gajda M; Korbut R; Olszanecki R
    Pharmacol Rep; 2019 Aug; 71(4):551-555. PubMed ID: 31129318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free Fatty Acid Receptors in Health and Disease.
    Kimura I; Ichimura A; Ohue-Kitano R; Igarashi M
    Physiol Rev; 2020 Jan; 100(1):171-210. PubMed ID: 31487233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel identification of the free fatty acid receptor FFAR1 that promotes contraction in airway smooth muscle.
    Mizuta K; Zhang Y; Mizuta F; Hoshijima H; Shiga T; Masaki E; Emala CW
    Am J Physiol Lung Cell Mol Physiol; 2015 Nov; 309(9):L970-82. PubMed ID: 26342087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free Fatty Acid Receptors (FFARs) in Adipose: Physiological Role and Therapeutic Outlook.
    Al Mahri S; Malik SS; Al Ibrahim M; Haji E; Dairi G; Mohammad S
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free Fatty Acid Receptors (FFARs): Emerging Therapeutic Targets for the Management of Diabetes Mellitus.
    Loona DPS; Das B; Kaur R; Kumar R; Yadav AK
    Curr Med Chem; 2023; 30(30):3404-3440. PubMed ID: 36173072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiological Relevance and Therapeutic Outlook of GPR43 in Atherosclerosis.
    Tang MY; Xie H; Tao JT; Zhang C; Luo YH; Zhang C; Peng SQ; Xie LX; Lv WB; Zhang C; Huang L
    Biochem Cell Biol; 2024 Jul; ():. PubMed ID: 39013204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Influence of the FFAR4 Agonist TUG-891 on Liver Steatosis in ApoE-Knockout Mice.
    Kiepura A; Suski M; Stachyra K; Kuś K; Czepiel K; Wiśniewska A; Ulatowska-Białas M; Olszanecki R
    Cardiovasc Drugs Ther; 2023 Jan; ():. PubMed ID: 36705799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo activation of leukocyte GPR120/FFAR4 by PUFAs has minimal impact on atherosclerosis in LDL receptor knockout mice.
    Shewale SV; Brown AL; Bi X; Boudyguina E; Sawyer JK; Alexander-Miller MA; Parks JS
    J Lipid Res; 2017 Jan; 58(1):236-246. PubMed ID: 27811230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-1β and TNFα inhibit GPR120 (FFAR4) and stimulate GPR84 (EX33) and GPR41 (FFAR3) fatty acid receptor expression in human adipocytes: implications for the anti-inflammatory action of n-3 fatty acids.
    Muredda L; Kępczyńska MA; Zaibi MS; Alomar SY; Trayhurn P
    Arch Physiol Biochem; 2018 May; 124(2):97-108. PubMed ID: 28835131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decoy bypass for appetite suppression in obese adults: role of synergistic nutrient sensing receptors GPR84 and FFAR4 on colonic endocrine cells.
    Peiris M; Aktar R; Reed D; Cibert-Goton V; Zdanaviciene A; Halder W; Robinow A; Corke S; Dogra H; Knowles CH; Blackshaw A
    Gut; 2022 May; 71(5):928-937. PubMed ID: 34083384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Involvement of the Free Fatty Acid Receptor GPR120/FFAR4 in the Development of Nonalcoholic Steatohepatitis].
    Nakamoto K; Tokuyama S
    Yakugaku Zasshi; 2019; 139(9):1169-1175. PubMed ID: 31474633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-Chain Fatty Acid Receptors and Cardiovascular Function.
    Lymperopoulos A; Suster MS; Borges JI
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free Fatty Acid Receptor 4 (GPR120) Stimulates Bone Formation and Suppresses Bone Resorption in the Presence of Elevated n-3 Fatty Acid Levels.
    Ahn SH; Park SY; Baek JE; Lee SY; Baek WY; Lee SY; Lee YS; Yoo HJ; Kim H; Lee SH; Im DS; Lee SK; Kim BJ; Koh JM
    Endocrinology; 2016 Jul; 157(7):2621-35. PubMed ID: 27145004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the Fatty Acid Receptors GPR84 and GPR120 and Cytodifferentiation of Epithelial Cells in the Gastric Mucosa of Mouse Pups in the Course of Dietary Transition.
    Widmayer P; Kusumakshi S; Hägele FA; Boehm U; Breer H
    Front Physiol; 2017; 8():601. PubMed ID: 28871231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free Fatty Acid Receptors as new potential therapeutic target in inflammatory bowel diseases.
    Bartoszek A; Moo EV; Binienda A; Fabisiak A; Krajewska JB; Mosińska P; Niewinna K; Tarasiuk A; Martemyanov K; Salaga M; Fichna J
    Pharmacol Res; 2020 Feb; 152():104604. PubMed ID: 31846762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.